mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.4 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.4 |